guanfacine - Page 1 | CARLAT PUBLISHING

Research Update

Long-Term Cardiovascular Risks of ADHD Medications: A Closer Look

April 1, 2025

Josh Feder, MD. Dr. Feder has no financial relationships with companies related to this material.

We know that stimulant medications for ADHD can reduce chronic health conditions and extend healthy years for patients. But are there cardiovascular risks from these or non-stimulant medications used for ADHD? In this research update, we review a study that helps clarify the risks of long term use in youth and adults.

Research Update

Guanfacine Is Effective and Safe for Children, Adolescents, and Adults

January 1, 2025

Heather Goff, MD

Heather Goff, MD. Dr. Goff has no financial relationships with companies related to this material.

Guanfacine is a popular second-line treatment for ADHD in children and teens. But what happens as our patients age into adulthood? Does guanfacine remain an effective medication in adults with ADHD? This research update covers a study that tries to answer this question.

Fact Sheet

Guanfacine (Intuniv, Tenex) for Children and Adolescents

September 1, 2023

Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

Dr. Feder, Dr. Tien, and Dr. Puzantian have no financial relationships with companies related to this material.
Full Fact Sheet Editorial Information

Guanfacine’s advantages over stimulants include no worsening of tic disorders, lack of misuse potential, and no insomnia.

How to Treat ADHD in Bipolar Disorder

November 5, 2021

Chris Aiken, MD.

Chris Aiken, MD. Editor-in-Chief of TCPR. Practicing psychiatrist, Winston-Salem, NC. Dr. Aiken has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Are stimulants risky in bipolar disorder? And which is safer – methylphenidate or amphetamine? Chris Aiken, MD, lays out a practical approach to the overlap of bipolar disorder and ADHD.

RESEARCH UPDATE

Beta Blockers and Depression: The Controversy Revisited

December 31, 2020

Sean Ransom, Ph.D

Sean Ransom, Ph.D Dr. Ransom has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

There is an age-old debate about whether blood pressure medications cause depression. This study is one of the largest to tackle the issue, and it suggests this risk may be limited to one class of antihypertensives in particular.

Guanfacine ER for Adults With ADHD?

October 6, 2020

Jesse Koskey, MD.

Jesse Koskey, MD. Dr. Koskey has disclosed that he has no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Children and adults respond differently to medications for ADHD. This first-of-its-kind trial tested out the pediatric-approved guanfacine ER (Intuniv) in adult ADHD.